Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics: Results from the BioVAP study
Journal of Critical Care Oct 12, 2017
Povoa P, et al. - This study aimed to elucidate the role of biomarker kinetics in the evaluation of response to antibiotics in patients with ventilator-associated pneumonia (VAP). VAP patients with poor outcome could be detected via C-reactive protein kinetics, as soon as four days after the initiation of treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
